Which hedge funds own ELVN? ENLIVEN THERAPEUTICS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
8 of the hedge funds tracked by WhaleCreep disclosed a position in ELVN (ENLIVEN THERAPEUTICS INC) in their Q2 2026 13F filings, worth $217.6m in total. The largest holder by portfolio weight is Avidity Partners at 4.5% of its book. 2 managers opened a new position this quarter: Marshall Wace, Tudor Investment.
8tracked managers holding
2opened this quarter
0exited this quarter
Which hedge funds hold ELVN? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Avidity Partners | Q2 2026 | 4.5% | $27.9m | 550,000 | 38% | added |
| Citadel Advisors | Q2 2026 | 0.1% | $105.0m | 2,068,992 | 19% | added |
| Woodline Partners | Q2 2026 | 0.1% | $17.6m | 347,142 | 15% | added |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $1.7m | 32,718 | 47% | added |
| Marshall Wace | Q2 2026 | 0.0% | $27.0m | 532,269 | – | new |
| Millennium Management | Q2 2026 | 0.0% | $20.9m | 411,362 | 19% | added |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $15.5m | 305,703 | 58% | added |
| Tudor Investment | Q2 2026 | 0.0% | $2.0m | 40,118 | – | new |
How has hedge fund ownership of ELVN changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 8 | $217.6m |
| Q1 2026 | 6 | $117.9m |
| Q4 2025 | 4 | $30.4m |
| Q3 2025 | 6 | $51.3m |
| Q2 2025 | 6 | $76.2m |
| Q1 2025 | 6 | $36.0m |
| Q4 2024 | 2 | $37.2m |
| Q3 2024 | 2 | $47.7m |
| Q2 2024 | 3 | $67.1m |
| Q1 2024 | 2 | $44.3m |
| Q4 2023 | 2 | $34.9m |
| Q3 2023 | 2 | $34.4m |
| Q2 2023 | 2 | $44.1m |
| Q1 2023 | 3 | $48.0m |
Counts every tracked manager that disclosed ELVN in that quarter's filing, including managers that have since stopped filing.